insights_auto
Why is ARGNF down 15.58%?
Dive Deeperchevron_right
ARGNF:OTCMKTS
argenx SE
$ 790.15
arrow_downward
-15.58%(-145.85) 1D
10-р сарын 13, 16:00:00 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Open
$ 790.15
High
$ 790.15
Low
$ 790.15
Mkt. cap
51.38 тэрбум
Avg. vol.
14.00
Volume
30.00
52-wk high
$ 1,020.00
52-wk low
$ 708.72
Beta
0.46
Shares outstanding
62.89 сая
No. of employees
2 мян
Open
$ 790.15
High
$ 790.15
Low
$ 790.15
Mkt. cap
51.38 тэрбум
Avg. vol.
14.00
Volume
30.00
52-wk high
$ 1,020.00
52-wk low
$ 708.72
Beta
0.46
Shares outstanding
62.89 сая
No. of employees
2 мян
News stories
From web sources and news partners
Simply Wall Street
·
5 цагийн өмнө
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
ad-hoc-news.de
·
16 цагийн өмнө
Oppenheimer cuts target to USD 1,038 for Argenx stock
ad-hoc-news.de
·
19 цагийн өмнө
Argenx stock pre-market at EUR 718.20
ad-hoc-news.de
·
1 өдрийн өмнө
Baird cuts target for Argenx stock to USD 823.00
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE